Lorcasérine (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lorcasérine" in French language version.

refsWebsite

Global rank French rank

low place

8,434^th place

2,374^th place

298^th place

1,735^th place

168^th place

1aspetjournals.org

6,663^rd place

5,973^rd place

1,226^th place

347^th place

222^nd place

129^th place

2,393^rd place

506^th place

low place

3,702^nd place

aspetjournals.org

jpet.aspetjournals.org

(en) Thomsen WJ, Grottick AJ, Menzaghi F et al. « Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization » J Pharmacol Exp Ther, 2008;325:577–587

bmj.com

(en) Rueda-Clausen CF, Padwal RS, « Pharmacotherapy for weight loss » BMJ, 2014;348:g3526

endocrine.org

press.endocrine.org

(en) Martin CK, Redman LM, Zhang J et al. « Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure » J Clin Endocrinol Metab, 2010;96:837–845
(en) Fidler MC, Sanchez M, Raether B et al. « A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial » J Clin Endocrinol Metab, 2011;96:3067–3077

jci.org

(en) Meltzer H, Roth BL, « Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs » J Clin Invest, 2013;123:4986–4991

nejm.org

(en) Smith SR, Weissman NJ, Anderson CM et al. « Multicenter, placebo-controlled trial of lorcaserin for weight management » N Engl J Med, 2010;363:245–256
(en) Colman E, Golden J, Roberts M, Egan A, Weaver J, Rosebraugh C, « The FDA’s assessment of two drugs for chronic weight management » N Engl J Med, 2012;367:1577-9

qmul.ac.uk

chem.qmul.ac.uk

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.

thelancet.com

Bohula EA, Scirica BM, Inzucchi SE et al. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial, Lancet, 2018;392:2269-2279

wiley.com

onlinelibrary.wiley.com

(en) O’Neil PM, SmithSR, Weissman NJ et al. « Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study » Obesity (Silver Spring), 2012;20:1426–1436